[
  {
    "ts": null,
    "headline": "Edwards Lifesciences Stock: Is Wall Street Bullish or Bearish?",
    "summary": "Although Edwards Lifesciences has outpaced the broader market over the past year, analysts remain measured in their expectations, maintaining a cautiously optimistic view as they look for continued execution and sustained growth drivers.",
    "url": "https://finnhub.io/api/news?id=c4e64c0882ec3a3ff2b6e1a1a2c63e237d621683020c0898beb9d3819cf83f76",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1762858722,
      "headline": "Edwards Lifesciences Stock: Is Wall Street Bullish or Bearish?",
      "id": 137449100,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "EW",
      "source": "Yahoo",
      "summary": "Although Edwards Lifesciences has outpaced the broader market over the past year, analysts remain measured in their expectations, maintaining a cautiously optimistic view as they look for continued execution and sustained growth drivers.",
      "url": "https://finnhub.io/api/news?id=c4e64c0882ec3a3ff2b6e1a1a2c63e237d621683020c0898beb9d3819cf83f76"
    }
  },
  {
    "ts": null,
    "headline": "Edwards Lifesciences (EW): Exploring Valuation as Earnings Upgrades and Guidance Fuel Options Market Volatility",
    "summary": "Edwards Lifesciences (EW) shares have drawn fresh attention as heightened implied volatility in the options market coincides with upgraded earnings estimates and increased full-year sales growth guidance. This signals increased anticipation ahead of upcoming earnings. See our latest analysis for Edwards Lifesciences. Edwards Lifesciences has enjoyed a solid stretch, with a 13.71% one-month share price return and a 15.83% gain year-to-date, further buoyed by upbeat earnings, a CFO transition...",
    "url": "https://finnhub.io/api/news?id=e3c18b1e5a4213daef0e9d98b6913b1731f264c4f1eb23e31b5af5ca89448143",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1762830957,
      "headline": "Edwards Lifesciences (EW): Exploring Valuation as Earnings Upgrades and Guidance Fuel Options Market Volatility",
      "id": 137438012,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "EW",
      "source": "Yahoo",
      "summary": "Edwards Lifesciences (EW) shares have drawn fresh attention as heightened implied volatility in the options market coincides with upgraded earnings estimates and increased full-year sales growth guidance. This signals increased anticipation ahead of upcoming earnings. See our latest analysis for Edwards Lifesciences. Edwards Lifesciences has enjoyed a solid stretch, with a 13.71% one-month share price return and a 15.83% gain year-to-date, further buoyed by upbeat earnings, a CFO transition...",
      "url": "https://finnhub.io/api/news?id=e3c18b1e5a4213daef0e9d98b6913b1731f264c4f1eb23e31b5af5ca89448143"
    }
  }
]